Adient Formed a Joint Venture with SCI to Drive Growth in China
Adient (NYSE:ADNT) completed acquisition of a 49% equity stake in SCI (Zhangjiakou) Co., Ltd. and formed a strategic joint venture on Dec. 8, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Adient (NYSE:ADNT) completed acquisition of a 49% equity stake in SCI (Zhangjiakou) Co., Ltd. and formed a strategic joint venture on Dec. 8, 2025.
The JV will develop and manufacture automotive seating solutions for the China market with a focus on serving key Chinese OEMs. The partnership combines Adient's global technology with SCI's local insights to accelerate development and mass production, expand market share, and strengthen Adient's local footprint in China.
Positive
- Acquired 49% equity stake in SCI (Zhangjiakou) on Dec. 8, 2025
- Joint venture dedicated to development and mass production of seating for China OEMs
- Combines Adient global technology with SCI local insights to accelerate product rollout
Negative
- None.
Details
News Market Reaction – ADNT
On Dec 8, the day this news came out, ADNT closed 1.24% above the previous close.
Data tracked by StockTitan Argus for the Dec 8 session.
Key Figures
- Equity stake
- 49%
- Adient acquisition in SCI joint venture
- Q4 GAAP net income
- $18M
- Q4 fiscal 2025 results
- Q4 adjusted EBITDA
- $226M
- Q4 fiscal 2025 results
- FY25 free cash flow
- $204M
- Full-year fiscal 2025
- Gross debt
- $2.4B
- Balance sheet at Sept. 30, 2025
- Cash balance
- $958M
- Balance sheet at Sept. 30, 2025
- FY25 revenue guidance
- ~$14.4B
- Raised FY25 outlook
- FY25 adj. EBITDA guidance
- ~$875M
- Raised FY25 outlook
Historical Context
-
Reported Q4 and full-year results with guidance for FY26.
-
Co-developed dynamic seat safety solution ready for mass production.
-
Scheduled Q4 FY2025 earnings conference call and webcast details.
-
Appointed new VP of FP&A and Investor Relations with auto experience.
-
Strong Q3 2025 results and raised FY25 guidance with higher EBITDA.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
joint venture financial
OEMs technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
This collaboration represents another strategic move for Adient in strengthening its presence in
The new joint venture will combine Adient's global technology expertise with SCI's local insights to accelerate the development and mass production of innovative seating products. Together, the companies will provide industry-leading automotive seating solutions that cater to both local and global trends for OEMs.
This joint venture marks an important milestone in Adient's continued investment and commitment to the
About Adient:
Adient (NYSE: ADNT) is a global leader in automotive seating. With more than 65,000 employees in 29 countries, Adient operates ~200 manufacturing/assembly plants worldwide. We produce and deliver automotive seating for all major OEMs. From complete seating systems to individual components, our expertise spans every step of the automotive seat-making process. We take our products from research and design to engineering and manufacturing — and into millions of vehicles every year. For more information on Adient, please visit www.adient.com.
View original content:https://www.prnewswire.com/news-releases/adient-formed-a-joint-venture-with-sci-to-drive-growth-in-china-302634743.html
SOURCE Adient
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.